Maze Therapeutics Launches with $191 Million to Focus on Translating Genetic Insights into New MedicinesAraceli Richardson2020-08-18T00:57:31-07:00February 28, 2019|
Halozyme Announces FDA Approval Of Herceptin Hylecta™Araceli Richardson2020-08-18T00:57:58-07:00February 28, 2019|
Black Diamond Therapeutics Closes $85 Million Series B FinancingAraceli Richardson2020-08-18T00:57:58-07:00January 9, 2019|
Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing CancerAraceli Richardson2020-08-18T00:57:59-07:00December 18, 2018|
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics PipelineAraceli Richardson2020-08-18T00:57:59-07:00September 14, 2018|
Roivant Adds Investigational Therapeutic for the Treatment of Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis to PipelineAraceli Richardson2020-08-18T00:57:59-07:00September 4, 2018|
ORIC Pharmaceuticals Announces $50 Million Series C Financing to Support Novel Therapies for Treatment-Resistant CancersAraceli Richardson2020-08-18T00:57:59-07:00February 21, 2018|
Roche and Ignyta Reach Definitive Merger AgreementAraceli Richardson2020-08-18T00:57:59-07:00December 22, 2017|
FDA Approves Genentech’s RITUXAN HYCELA, A Subcutaneous Rituximab Coformulated With Halozyme ENHANZE TechnologyAraceli Richardson2020-08-18T00:57:59-07:00June 22, 2017|
Flex Pharma Announces Pricing Of Initial Public OfferingAraceli Richardson2020-08-18T00:57:59-07:00January 28, 2015|
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary ImmunodeficiencyAraceli Richardson2020-08-18T00:57:59-07:00September 12, 2014|
